Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Ensure for Osteoarthritis

This study wants to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.

Official registry: https://clinicaltrials.gov/study/NCT04210284 · NYU Langone Health · enrollment listed as 72

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Ensure. The registry lists allocation as randomized. This study wants to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.

They plan to enroll about 72 people at 2 sites. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Oral Nutritional Optimization in Total Joint Arthroplasty

Interventions: Ensure

Primary outcome (registry wording): Changes in the patients' albumin, pre-albumin, and/or transferrin levels

Who it is for (from inclusion criteria)

  • Ages 55 Years to any
  • Patient are current candidates for elective primary total hip and total knee arthroplasty
  • Patients ≥55 years of age but ≤ 95
  • Patients who meet at least one of the following three laboratory criteria for malnutrition:
  • TSerum Albumin: ≤3.5 mg/dl Pre-Albumin: \<15 mg/dl Transferrin: \<200 mg/dl

Public study contact (from the registry)

Daniel Waren

212-598-6245

Daniel.waren@nyulangone.org

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

2 listed

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseClermont-Ferrand
Not a traditional drug phase: Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness. for Joint Osteoarthritis

Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern.

NCT04375280 · Official ClinicalTrials.gov record · University Hospital, Clermont-Ferrand

RecruitingNot a traditional drug phaseHelsinki
Not a traditional drug phase: Trapeziectomy for Thumb Osteoarthritis

A multi-center randomly assigned compared with a dummy treatment clinical trial which determines the how well it works of trapeziectomy in patients with persistent painful osteoarthritis at the base of the thumb. The primary outcome is patient reported evaluation of pain and function of the wrist and hand at 6 months after the randomization to treatment group.

NCT05127005 · Official ClinicalTrials.gov record · Tampere University Hospital

FAQ about this NCT record

Is NCT04210284 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT04210284?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT04210284?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary